Felidale 2.5 mg Coated Tablets for Cats

দেশ: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: VMD (Veterinary Medicines Directorate)

এখন এটা কিনুন

সক্রিয় উপাদান:

Thiamazole

থেকে পাওয়া:

Dechra Limited

এটিসি কোড:

QH03BB02

INN (আন্তর্জাতিক নাম):

Thiamazole

ফার্মাসিউটিকাল ফর্ম:

Coated tablet

প্রেসক্রিপশন টাইপ:

POM-V - Prescription Only Medicine – Veterinarian

থেরাপিউটিক গ্রুপ:

Cats

থেরাপিউটিক এলাকা:

Anti Hormone Agent

অনুমোদন অবস্থা:

Authorized

অনুমোদন তারিখ:

2012-05-01

পণ্য বৈশিষ্ট্য

                                Revised: August 2018
AN: 02223/2017
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Felidale 2.5 mg Coated Tablets for Cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 tablet contains:
ACTIVE SUBSTANCE:
Thiamazole 2.5 mg
EXCIPIENTS:
Titanium Dioxide (E171) 1.12 mg
Erythrosine (E127) 0.01 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Coated tablet.
Pink sugar-coated biconvex tablets, 5.5 mm diameter.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the stabilisation of hyperthyroidism in cats prior to surgical
thyroidectomy.
For the long-term treatment of feline hyperthyroidism.
4.3
CONTRAINDICATIONS
Do not use in cats suffering from systemic disease such as primary
liver
disease or diabetes mellitus.
Do not use in cats showing signs of autoimmune disease.
Do not use in animals with disorders of white blood cells, such as
neutropaenia and lymphopaenia.
Do not use in animals with platelet disorders and coagulopathies
(particularly
thrombocytopaenia).
Do not use in cats with hypersensitivity to thiamazole or the
excipient,
polyethylene glycol.
Do not use in pregnant or lactating females.
Please refer to section 4.7.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Revised: August 2018
AN: 02223/2017
Page 2 of 6
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
As thiamazole can cause haemoconcentration, cats should always have
access to drinking water.
If more than 10 mg per day is required animals should be monitored
particularly carefully.
Use of the product in cats with renal dysfunction should be subject to
careful
risk : benefit assessment by the clinician. Due to the effect
thiamazole can
have on reducing the glomerular filtration rate, the effect of therapy
on renal
function should be monitored closely as deterioration of an underlying
condition may occur.
Haematology must be monitored due to risk of leucopaenia or haemolytic
anaemia.
Any animal that suddenly a
                                
                                সম্পূর্ণ নথি পড়ুন
                                
                            

এই পণ্য সম্পর্কিত সতর্কতা অনুসন্ধান করুন

দস্তাবেজ ইতিহাস দেখুন